The FDA is reporting that Zoll has recalled its AutoPulse Nxt Resuscitation System due to a failure code that may cause the device to stop delivering chest compressions or fail to compress deeply enough, according to an FDA alert.
The FDA is reporting that Zoll has recalled its AutoPulse Nxt Resuscitation System due to a failure code that may cause the device to stop delivering chest compressions or fail to compress deeply enough, according to an FDA alert.
Read More
Zoll has completed its previously announced acquisition of certain assets of Vyaire Medical’s ventilator business.
Read More
The Zoll AED Plus defibrillator is now approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR, according to the company.
Read More
Zoll has secured the winning bid to acquire Vyaire Medical’s ventilator business, which is being sold as part of Vyaire’s Chapter 11 bankruptcy proceedings.
Read More
ZOLL has updated the guides for its 731 Series Ventilator family to address MRI safety information and prevent potential device failures.
Read More
A contract with Zoll will offer the Vizient Inc healthcare systems access to the TherOx Supersaturated Oxygen Therapy, which can benefit patients facing the most lethal of heart attacks, the LAD-STEMI.
Read More
The Zoll AED 3 defibrillator is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR, according to the company.
Read More
RT looks at the latest ventilators and critical care products on the market from manufacturers Bio-Med Devices, Breas Medical, Dräger, Getinge, Movair, Turn Medical, and Zoll.
Read More
The US FDA approved Zoll’s remedē System, a central sleep apnea therapy, for conditional use with magnetic resonance imaging (MRI).
Read More
The first patient has enrolled in a study to assess the clinical utility and cost-effectiveness of Zoll TherOx SuperSaturated Oxygen (SSO2) Therapy.
Read More
Zoll Medical Corp’s TherOx SuperSaturated Oxygen (SSO2) Therapy has been awarded a group purchasing agreement for Diagnostic and Interventional Cardiology Catheters (DIC) with Premier Inc, effective as of July 1, 2022.
Read More
Zoll will exhibit its TherOx SuperSaturated Oxygen (SSO2) Therapy at the Vizient Innovative Technology Exchange on October 17.
Read More
The first patient has enrolled in a post-approval study further evaluating TherOx SuperSaturated Oxygen (SSO2) Therapy for the treatment of LAD-STEMI, the most severe form of heart attack.
Read More
The Centers for Medicare & Medicaid Services issued a new ICD-10-PCS code for TherOx SuperSaturated Oxygen (SSO2) Therapy, according to Zoll Medical Corp.
Read More
Zoll Medical Corp launched the Zoll Arrhythmia Management System, which adds biometric data including respiratory rate to the ECG information provided by traditional MCT devices.
Read More
Zoll launched its Arrhythmia Management System, a mobile cardiac telemetry solution that adds biometric data to traditional MCT data to help physicians make more informed treatment plans.
Read MoreZoll Foundation, which issues funding to young investigators in the fields of resuscitation and acute critical care, announced a grant application deadline is March 31, 2022.
Read More
Zoll Medical Corp has successfully completed its acquisition of Itamar Medical Ltd and its at-home sleep testing devices.
Read More
Zoll Medical Corp and Itamar Medical Ltd have signed a definitive agreement for Zoll to acquire Itamar Medical for a total value of approximately $538 million.
Read More
The American Medical Association (AMA) CPT Editorial Panel issued a new Category III CPT code for the TherOx SuperSaturated Oxygen (SSO2) Therapy, according to Zoll Medical Corp.
Read More
Zoll Medical received US FDA approval for its remedē EL-X System to treat moderate to severe central sleep apnea (CSA) in adult patients.
Read More
Zoll Medical Corp has received FDA 510(k) clearance to release the TBI Dashboard feature on its Propaq M monitor and Propaq MD monitor/defibrillator in the United States.
Read More
RT looks at the latest ventilators and critical care products on the market from manufacturers like Breas Medical, Dräger, Philips, Zoll, Hans Rudolph, and more.
Read More
Five-year results from the remedē System post approval study showed sustained safety and efficacy of transvenous phrenic nerve stimulation for the treatment of moderate to severe central sleep apnea, according to Zoll Medical Corp.
Read More
